Galderma soothes ECM with 15% pop after Sfr2bn IPO
The biggest IPO of 2024 so far in Europe has delivered a welcome bounce in the aftermarket
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts